University of Pittsburgh

University of Pittsburgh Smoking Research Studies

Ready to Stop Smoking?

The University of Pittsburgh seeks healthy smokers aged 18-65 who are already planning to quit smoking for a 6-week research study on the short-term effects of an oral drug on smoking behavior, craving, and mood. This experimental drug was developed to reduce cognitive impairment, one symptom of tobacco withdrawal, suggesting it may also help reduce smoking. It is not yet FDA-approved, and this is not a treatment study.

You will be asked to take study drug that may or may not contain the active component for 14 days. Research study participants will be compensated.

Although this study is not a treatment trial, everyone who completes the study will be offered optional brief counseling and Zyban (bupropion), FDA-approved for smoking cessation, at no cost after the study is over to help them quit permanently.

For more information and to see if you qualify: